DOI: 10.12809/hkmj164847
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
LETTER TO THE EDITOR
Re: Alternatives to colonoscopy for population-wide
colorectal cancer screening
John SM Leung, FCSHK, FHKAM (Surgery)
St Paul’s Hospital,
Causeway Bay, Hong Kong
Corresponding author: Dr John SM Leung (leungsiumanjohn@yahoo.com.hk)
To the Editor—I much appreciate the timely
publication of the review paper, “Alternatives to
colonoscopy for population-wide colorectal cancer
screening,” by Leung et al.1 We are facing an ageing
population and a large proportion of our elderly
patients have coronary and other arterial disorders
for which they are prescribed aspirin. If stents have
been deployed they are prescribed dual antiplatelet
therapy. Direct interventional procedures such
as colonoscopy might not be the ideal first-line
screening procedure due to the risk of bleeding.
Computed tomographic (CT) virtual colonoscopy
might be an alternative. The CT imaging may not
be comparable with the colonoscope, especially for
the sub-centimetre polyp, but it has the advantage
of picking up extraluminal lesions like epiploic
appendagitis. More importantly the CT imaging
also serves to screen the whole abdomen beyond the
large intestine. The following case report illustrates
this issue.
A 78-year-old retired professor complained of
ill-defined pain in the chest. She was diagnosed to
have coronary artery disease and two drug-eluting
stents were deployed. The discomfort persisted
and more medications were given. She became
constipated and her haemorrhoids started to bleed.
At this stage colonoscopy screening for colorectal
cancer was considered but was reckoned inadvisable
because of her dual antiplatelet therapy. A CT
colonoscopy was done and revealed a few polyps and
also a discreet tumour in the wall of the fundus of
the stomach. Gastroscopy had likewise been vetoed
because of the antiplatelet therapy. Nonetheless, the
CT image helped to define the tumour outline to the
extent that it was unlike the usual gastric carcinoma.
Blood test for a panel of tumour markers showed
that chromogranin A was strongly positive, thus
narrowing the diagnosis to a gastric neuroendocrine
tumour.
The standard treatment of a neuroendocrine
tumour is surgical excision and so we are regrettably
still faced with the problem of dual antiplatelet
therapy and the risk of perioperative haemorrhage.
Reference
1. Leung WC, Foo DC, Chan TT, et al. Alternatives to
colonoscopy for population-wide colorectal cancer
screening. Hong Kong Med J 2016;22:70-7.